Loading data...
Loading data...
Analyzing the stock…
70
Gathering technical, fundamental, and market data — a few seconds
Industrials · ·
$107.56
▼ $0.04 (-0.0%)
Market data updated: 09/19 11:42 AM
Fundamentals updated: 09/18/2026
News analyzed: 09/19/2026
Market Cap
$25.11B
Day Range
$106.81 - $108.21
52-Week Range
$105.29 - $154.27
Beta
—
Next Earnings
26.10.2026
Support
$105.48
Resistance
$127.16
XYL is a stock from the Industrials sector — Manufacturing, aerospace, defense, and infrastructure — closely tied to capital-investment cycles and economic growth.
-24.3% (1Y)
Strengths: 9/28 factors positiveRisk: Medium
This score and all analysis on this page are for informational and educational purposes only and do not constitute investment advice. Read the full disclaimer
Weighted: Technical 25% · Fundamental 20% · Growth 15% · Valuation 15% · News 10% · Quality 10% · Risk 5%
Overall Score
🟡 Mixed
Technical Trend
🔴 Bearish
Insiders
🔴 Bearish
Computed directly from the same signals behind the score above — not AI-generated.
Biggest positive driver
Operating margin stability
Operating margin is stable or improving over time
Quality
Biggest negative driver
Calmar Ratio (return vs. drawdown)
Calmar: 0.14 (3y annualized return 4.3% / max drawdown 30.9%)
Risk
What to watch next
When today echoes the past.
NO RELIABLE ECHO FOUND
Only 2 historical analog(s) found after removing overlapping dates — too few for a statistically meaningful comparison.
Historical matches considered: 2
TIME ECHO identifies historical situations that resemble the current market state. Historical outcomes are not guarantees of future performance. Similarity does not imply causation, and results may change as new data becomes available.
🗓️ What Changed This Week
🌱 Building History
We don't have a real data point from a week ago for this stock yet. The weekly comparison will appear once enough history has accumulated.
📊 Score History
57
Today
—
30D
—
90D
—
1Y
🐂🐻 Investment Thesis
🐂 Bull Case
🐻 Bear Case
🔍 What Could Prove This Wrong
This isn't a price-direction forecast — just a synthesis of real, already-computed data, and future conditions that could change the picture.
🧬 STOCK DNA
This stock's profile across 8 real dimensions — a research tool, not a recommendation
Growth
56
Quality
63
Value
50
Momentum
38
Risk
54
Sentiment
98
Fundamental
64
Institutional
0
Stocks with a similar DNA right now
SCANNING XYL...
Recent media coverage of Xylem Inc. has primarily focused on its position within the expanding global and European pumps market, with projections highlighting steady growth driven by smart pumps, IoT integration, and industrial demand. Analysts have also scrutinized the company’s stock performance, noting a 7.1% decline since its last earnings report, while Jefferies recently raised its price target to $150. Additionally, Xylem’s leadership experience was briefly mentioned in connection to a CFO appointment at GE HealthCare Technologies. No company-specific operational or strategic developments were detailed beyond market trends.
AI summary based on English-language news sources only — not investment advice.
Everyone's writing about Xylem Inc.. News trend score: 98. Reason: 10 of the last 20 articles are positive, versus 2 negative.
News trend analysis is based on article sentiment only, and is not investment advice or financial counsel. Read the full disclaimer
🌡️ Emotional Temperature
18
🎯 Conviction (vs. Emotion)
42
Psychology
61
Fundamentals
64
Technical
38
Valuation
50
The price is holding at a real, documented historical support/resistance level (a 50-day high or low).
The stock is moving in lockstep with its peers at the same intensity, rather than on its own data.
Extreme momentum, price far above its moving average, and a large premium over fair value.
Price, volume, and sentiment accelerating together — a sign investors are chasing the price, not just following it.
A sharp drop, unusual volume, and negative news sentiment all at once — selling pressure that looks emotional.
Price (3M)
-3%
Market Narrative
64
Fundamental Reality
42
Narrative Gap
+22
🔀 Psychology Acceleration
News attention/sentiment is running well ahead of the price move itself.
🧠 StockIQ Psychologist
Market behavior suggests the dominant anchoring score (71) reflects traders focusing on the stock’s 1.4 % distance from support. Low momentum, RSI, and volume keep excitement states such as FOMO and euphoria muted, while modest herding indicates some peer‑related trading. The modest narrative‑reality gap (10 points) hints that the prevailing story may not fully align with underlying performance. A potential bias toward anchoring may be limiting broader price reassessment. The key open question is whether price will decisively move away from the support level.
Updated: 09/10/2026, 07:09 AM
What could change this?
👥 What the crowd believes
"Europe pump market valued at USD 17.50 billion in 2025 and projected to reach USD 22.53 billion by 2031"
"Profiling Grundfos, Xylem, Ebara, Wilo, Flowserve, and 55 other key players"
"Xylem (XYL) Down 7.1% Since Last Earnings Report: Can It Rebound?"
"Buy 3 Ideal September Dividend Dogs Out Of Barron’s 58 August Picks"
📈 11D Investor Psychology
Signal classification confidence: High (confidence in the behavioral read, not a price prediction). Describes observable market behavior, not what any individual investor thinks, and is not a buy/sell signal.
🏛️ Investor DNA — Historical Investors
A Historical Strategy Simulation: assuming each investor follows their documented principles, how would they rate this stock today? This is not a prediction of what they would actually do.
🟢 Best match
Samuel Armstrong Nelson — 78/100
🔴 Weakest match
Benjamin Graham (Enterprising Investor) — 25/100
🗣️ Why do they disagree?
The methodologies for XYL split sharply between bullish and cautious camps, reflecting starkly different priorities. At the top, Samuel Armstrong Nelson’s near-perfect score and Jack Schwager’s disciplined setup highlight technical or cyclical opportunities—Nelson sees it as oversold, while Schwager emphasizes favorable risk/reward. Meanwhile, long-term compounders like Edgar Lawrence Smith and Morgan Housel also lean positive, framing it as a patient-holder’s candidate with quiet growth potential. However, the middle tier—including Howard Marks (both cycle and general) and Gerald Loeb—cautions that while the business may be sound, expectations or risk levels temper enthusiasm. On the other end, the bearish crowd, from Benjamin Graham’s defensive criteria to Jesse Livermore’s trend-following rule, dismisses it outright, with Fisher and the efficient-market camp arguing it lacks the quality or evidence to justify active selection. The divide underscores whether XYL’s appeal lies in technical timing, patient accumulation, or fundamental flaws.
Samuel Armstrong Nelson
The ABC of Stock Speculation (1903)
🟢 78
Cycle position looks favorable — closer to oversold than overbought
Key question
Is the price overextended, or is there still room to move?
Fact → Principle → Simulation
Charles Mackay
Extraordinary Popular Delusions and the Madness of Crowds (1841)
🟢 76
No obvious signs of crowd mania
Key question
Am I being swept along with the crowd, or thinking for myself?
Fact → Principle → Simulation
Edgar Lawrence Smith
Common Stocks as Long-Term Investments (1924)
🟢 76
Looks like a real 'buy and hold for a decade' candidate
Key question
Is this a stock I'd be happy to hold and forget about for a decade?
Fact → Principle → Simulation
Morgan Housel
The Psychology of Money (2020)
🟢 73
The kind of quiet compounder a patient holder could actually stick with
Key question
Could I live with this volatility long enough for compounding to actually work?
Fact → Principle → Simulation
Jack Schwager
Market Wizards (1989)
🟢 70
A real, disciplined setup with favorable reward/risk
Key question
What's the risk/reward here, and where is my exit point?
Fact → Principle → Simulation
Gerald M. Loeb
The Battle for Investment Survival (1935)
🟡 64
Moderate risk to capital
Key question
How much capital could I lose here if I'm wrong?
Fact → Principle → Simulation
Howard Marks
The Most Important Thing (2011) / Mastering the Market Cycle (2018)
🟡 62
Mixed — a good business, but expectations may already be high
Key question
What is the market probably misunderstanding about the risk here?
Fact → Principle → Simulation
Walter Bagehot
Lombard Street (1873)
🟡 59
Adequate but not exceptional liquidity
Key question
Does this company have enough liquidity to survive real stress?
Fact → Principle → Simulation
Howard Marks (Market Cycle)
Mastering the Market Cycle (2018)
🟡 58
Somewhere in the middle of the cycle
Key question
Where are we in the cycle right now — near a hot extreme, or a cold one?
Fact → Principle → Simulation
Thorstein Veblen
The Theory of Business Enterprise (1904)
🟡 54
Mixed signal on whether growth translates to real profit
Key question
Is management building real value, or just building itself?
Fact → Principle → Simulation
Burton Malkiel & John Bogle
A Random Walk Down Wall Street (1973) / The Little Book of Common Sense Investing (2007)
🟡 49
Mixed case — the evidence for picking this stock over an index is not strong
Key question
Do I actually have an edge here, or do I just think I do?
Fact → Principle → Simulation
Philip Fisher
Common Stocks and Uncommon Profits (1958)
🟡 45
Doesn't show the quality/growth signature Fisher required
Key question
How exceptional is this business, really?
Fact → Principle → Simulation
Benjamin Graham
Security Analysis (1934) / The Intelligent Investor (1949)
🟡 38
Fails most of Graham's defensive criteria
Key question
Where is my margin of safety?
Fact → Principle → Simulation
Jesse Livermore
Reminiscences of a Stock Operator (1923) / How to Trade in Stocks (1940)
🟡 38
Negative trend — against Livermore's core rule of trading with the trend
Key question
What is the price telling me right now?
Fact → Principle → Simulation
Peter Lynch
One Up on Wall Street (1989)
🔴 31
Doesn't clear Lynch's growth-at-a-reasonable-price bar
Key question
Is the growth worth the price?
Fact → Principle → Simulation
Benjamin Graham (Enterprising Investor)
The Intelligent Investor (1949) — the Enterprising Investor chapters
🔴 25
Not statistically cheap enough for the Enterprising Investor's looser safety bar
Key question
Is the stock statistically cheap enough to justify the extra risk?
Fact → Principle → Simulation
Based on the last 280 trading days, calculated from real price data. Click an indicator for details and a chart.
🔴 Most indicators support a downtrend (3 bullish · 6 bearish · 1 neutral)
A market-structure read based purely on real price and volume data — not full classic Wyckoff schematic identification (Phase A-E), but a quantitative analysis of what can reliably be computed: trading ranges, "effort vs. result", volume within the range, and Spring/Upthrust detection.
The stock is in a clear downtrend with no defined trading range in the period examined.
Medium confidence
The Wyckoff Method, developed by Richard Wyckoff in the early 20th century, reads the balance of supply and demand through price and volume, based on the premise that large investors ("smart money") quietly accumulate shares before rallies and quietly distribute them before declines. The read here is based solely on real price and volume data — full, precise identification of classic Wyckoff patterns (such as Phases A-E) requires human chart-reading experience and judgment, so this is an approximate algorithmic read, not a substitute for professional analysis. This should not be considered investment advice.
Gross Margin
38.5%
Operating Margin
13.5%
Net Margin
10.6%
EBITDA Margin
19.9%
ROE
8.3%
ROA
5.4%
ROIC
—
EPS
$3.93
Cash
$1.48B
Total Debt
$1.94B
Current Ratio
1.63
Debt/Equity
0.17
אין נתונים היסטוריים זמינים.
Total dividend per share paid each year, over the last 5 years.
| Ex-Dividend Date | Amount per Share |
|---|---|
| 27.8.2026 | $0.430 |
| 28.5.2026 | $0.430 |
| 27.5.2026 | $0.430 |
| 24.2.2026 | $0.430 |
| 23.2.2026 | $0.430 |
| 25.11.2025 | $0.400 |
| 24.11.2025 | $0.400 |
| 28.8.2025 | $0.400 |
| 27.8.2025 | $0.400 |
| 29.5.2025 | $0.400 |
| 28.5.2025 | $0.400 |
| 18.2.2025 | $0.400 |
How is Fair Value calculated? →
Not enough cash-flow data to calculate a DCF model for this stock.
Book Value per Share
$47.05
Tangible Book Value per Share (Tangible NAV)
$3.59
Sentiment based on basic keywords (not AI) — 10 positive, 8 neutral, 2 negative out of the last 20 articles.
SeekingAlpha · 18.9.2026
Yahoo · 18.9.2026
Yahoo · 17.9.2026
Benzinga · 15.9.2026
Yahoo · 11.9.2026
Barchart · 11.9.2026
GlobeNewswire · 9.9.2026
SeekingAlpha · 5.9.2026
Yahoo · 31.8.2026
GlobeNewswire · 31.8.2026
Yahoo · 28.8.2026
GlobeNewswire · 28.8.2026
Yahoo · 27.8.2026
Zacks · 27.8.2026
Yahoo · 26.8.2026
Simply Wall St. · 26.8.2026
MT Newswires · 24.8.2026
SeekingAlpha · 21.8.2026
Simply Wall St. · 20.8.2026
Yahoo · 20.8.2026
Xylem Inc. (XYL) currently has a StockIQ AI score of 57/100, rated "Moderate". The score is a weighted average across up to 7 categories (technical, fundamental, growth, fair value, news, quality, risk), based on real data only.
XYL currently scores 57/100 (Moderate) across the categories we measure. StockIQ doesn't give buy/sell recommendations — use this as one data point in your own research, not as investment advice.
XYL's technical score is 38/100, which currently reads as bearish — based on real price/volume signals (moving averages, RSI, MACD, and more), not a prediction of what happens next.
Based on the real signals StockIQ computed: Operating margin is stable or improving over time; Debt/equity: 0.17; Current ratio: 1.63.
Based on the real signals StockIQ computed: Calmar: 0.14 (3y annualized return 4.3% / max drawdown 30.9%); Price is below the 50-day average; Price is below the 200-day average.
Yes — XYL has a real recorded dividend payment history on StockIQ. See the Dividends section on this page for the actual per-share amounts and dates.
Real transactions by officers and insiders, as reported to the SEC on Form 4 — 0 purchases and 1 sales out of the last 25 filings.
| Name | Transaction Type | Date | Shares | Change | Price |
|---|---|---|---|---|---|
| van der Berg Andrea Michele | Grant/Award from Employer | 1.9.2026 | 6,034 | +6,034 | $106.89 |
| van der Berg Andrea Michele | Grant/Award from Employer | 1.9.2026 | 1,693 | +1,693 | — |
| Johnston Joseph Patrick | Grant/Award from Employer | 1.9.2026 | 2,298 | +2,298 | $106.89 |
| Johnston Joseph Patrick | Grant/Award from Employer | 1.9.2026 | 645 | +645 | — |
| KOCH D CHRISTIAN | Grant/Award from Employer | 13.8.2026 | 1,247 | +1,247 | $120.27 |
| KOCH D CHRISTIAN | Grant/Award from Employer | 13.8.2026 | 1,247 | +1,247 | $120.27 |
| Harker Victoria D | Grant/Award from Employer | 14.5.2026 | 1,711 | +1,711 | $116.88 |
| FRIEL ROBERT F | Grant/Award from Employer | 14.5.2026 | 2,481 | +2,481 | $116.88 |
| Tretikov Lila | Grant/Award from Employer | 14.5.2026 | 1,711 | +1,711 | $116.88 |
| Morelli Mark D | Grant/Award from Employer | 14.5.2026 | 1,711 | +1,711 | $116.88 |
| Peribere Jerome A | Grant/Award from Employer | 14.5.2026 | 1,711 | +1,711 | $116.88 |
| Yadav Uday | Grant/Award from Employer | 14.5.2026 | 1,711 | +1,711 | $116.88 |
| ELLIS EARL RAY | Grant/Award from Employer | 14.5.2026 | 1,711 | +1,711 | $116.88 |
| Glatch Lisa | Grant/Award from Employer | 14.5.2026 | 1,711 | +1,711 | $116.88 |
| Glatch Lisa | Grant/Award from Employer | 14.5.2026 | 6,874 | +1,711 | $116.88 |
| Harker Victoria D | Grant/Award from Employer | 14.5.2026 | 18,586 | +1,711 | $116.88 |
| FRIEL ROBERT F | Grant/Award from Employer | 14.5.2026 | 38,706 | +2,481 | $116.88 |
| Morelli Mark D | Grant/Award from Employer | 14.5.2026 | 8,026 | +1,711 | $116.88 |
| Yadav Uday | Grant/Award from Employer | 14.5.2026 | 10,337 | +1,711 | $116.88 |
| Peribere Jerome A | Grant/Award from Employer | 14.5.2026 | 5,747 | +1,711 | $116.88 |
| ELLIS EARL RAY | Grant/Award from Employer | 14.5.2026 | 6,038 | +1,711 | $116.88 |
| Tretikov Lila | Grant/Award from Employer | 14.5.2026 | 10,406 | +1,711 | $116.88 |
| McShane Geri-Michelle | Exercise of Derivative Securities | 7.5.2026 | 3,147 | -3,147 | $86.76 |
| McShane Geri-Michelle | Open Market Sale | 7.5.2026 | 4,269 | -4,269 | $117.46 |
| McShane Geri-Michelle | Exercise of Derivative Securities | 7.5.2026 | 3,147 | -3,147 | — |
Official FINRA data — the number of shares open in short positions, plus daily short-sale activity.
8,031,075 shares short as of 2026-08-31 · vs. 7,729,575 on 2026-07-31
Official biweekly report (FINRA Rule 4560) — no real higher-frequency data exists for this metric.
65.9% of trading volume this week was short selling, vs. 63.2% the prior week
Based on daily short-sale volume (Reg SHO) — a different metric from the open short interest above: this is daily trading volume, not an open position, so it updates weekly rather than biweekly.
Full breakdown of every data type and its source: Data Sources · Methodology